Structural studies of the tethered N-terminus of the Alzheimer's disease amyloid-[beta] peptide
Alzheimer's disease is the most common form of dementia in humans and is related to the accumulation of the amyloid-[beta] (A[beta]) peptide and its interaction with metals (Cu, Fe, and Zn) in the brain. Crystallographic structural information about A[beta] peptide deposits and the details of t...
Saved in:
Published in: | Proteins, structure, function, and bioinformatics Vol. 81; no. 10; pp. 1748 - 1758 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Hokoben
Wiley Subscription Services, Inc
01-10-2013
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Alzheimer's disease is the most common form of dementia in humans and is related to the accumulation of the amyloid-[beta] (A[beta]) peptide and its interaction with metals (Cu, Fe, and Zn) in the brain. Crystallographic structural information about A[beta] peptide deposits and the details of the metal-binding site is limited owing to the heterogeneous nature of aggregation states formed by the peptide. Here, we present a crystal structure of A[beta] residues 1-16 fused to the N-terminus of the Escherichia coli immunity protein Im7, and stabilized with the fragment antigen binding fragment of the anti-A[beta] N-terminal antibody WO2. The structure demonstrates that A[beta] residues 10-16, which are not in complex with the antibody, adopt a mixture of local polyproline II-helix and turn type conformations, enhancing cooperativity between the two adjacent histidine residues His13 and His14. Furthermore, this relatively rigid region of A[beta] (residues, 10-16) appear as an almost independent unit available for trapping metal ions and provides a rationale for the His13-metal-His14 coordination in the A[beta]1-16 fragment implicated in A[beta] metal binding. This novel structure, therefore, has the potential to provide a foundation for investigating the effect of metal ion binding to A[beta] and illustrates a potential target for the development of future Alzheimer's disease therapeutics aimed at stabilizing the N-terminal monomer structure, in particular residues His13 and His14, and preventing A[beta] metal-binding-induced neurotoxicity.Proteins 2013; 81:1748-1758. © 2013 Wiley Periodicals, Inc. [PUBLICATION ABSTRACT] |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
ISSN: | 0887-3585 1097-0134 |
DOI: | 10.1002/prot.24312 |